A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer
Condition: Prostate Cancer Interventions: Drug: enzalutamide; Drug: enzalutamide Placebo; Drug: digoxin; Drug: rosuvastatin Sponsors: Astellas Pharma Global Development, Inc.; Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Crestor | Pfizer | Prostate Cancer | Research | Rosuvastatin | Study